Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Director Acquires $58,700.00 in Stock
Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Get Free Report) Director John B. Bode bought 10,000 shares of the firm’s stock in a transaction on Friday, July 12th. The stock was purchased at an average cost of $5.87 per share, with a total value of $58,700.00. Following the completion of the transaction, the director now directly owns […]
More Stories
Bread Financial Holdings, Inc. (NYSE:BFH) Director John J. Fawcett Buys 1,000 Shares
Bread Financial Holdings, Inc. (NYSE:BFH – Get Free Report) Director John J. Fawcett purchased 1,000 shares of the firm’s stock...
Cartier Resources (CVE:ECR) Hits New 12-Month High – Here’s Why
Cartier Resources Inc. (CVE:ECR – Get Free Report)’s share price hit a new 52-week high on Monday . The company...
Azzurro Capital Inc Sells 27,500 Shares of Travelzoo (NASDAQ:TZOO) Stock
Travelzoo (NASDAQ:TZOO – Get Free Report) major shareholder Azzurro Capital Inc sold 27,500 shares of the company’s stock in a...
Heineken (OTCMKTS:HEINY) Reaches New 12-Month Low – Here’s Why
Heineken (OTCMKTS:HEINY – Get Free Report) hit a new 52-week low on Wednesday . The company traded as low as...
Frontier (FRONT) Reaches Self Reported Market Cap of $8.46 Million
Frontier (FRONT) traded 0.2% higher against the US dollar during the one day period ending at 17:00 PM ET on...
Manifold Finance Price Reaches $4.10 on Top Exchanges (FOLD)
Manifold Finance (FOLD) traded 4.4% higher against the U.S. dollar during the 1-day period ending at 17:00 PM E.T. on...